10 completed, 3 unknown, 1 active not recruiting. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Completed 10, Unknown 3, Active not recruiting 1 |
Follow Amiloride: new trials by email Literature Review of Amiloride trials Research Report on Amiloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium Anhydrous Amiloride Hydrochloride, Placebo - Bipolar Disorder | Phase 4 | Active not recruiting | Assistance Publique - Hôpitaux de Paris | 148 | 2023-01-11 | 2025-05-09 |
| Treatment of Vascular Stiffness in ADPKD Sodium chloride (NaCl), Placebo, Amiloride Hcl 5mg Tab - Autosomal Dominant Polycystic Kidney | Phase 4 | Completed | Erasmus Medical Center | 46 | 2022-03-11 | 2025-08-17 |
| Comparison of Spironolactone and Amiloride on Home Blood Pressure in Resistant Hypertension Spironolactone, Amiloride - Resistant Hypertension | Phase 4 | Completed | Yonsei University | 118 | 2020-11-16 | 2024-09-24 |
| A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein Amiloride, Hydrochlorothiazide - Chronic Kidney Diseases | Phase 4 | Completed | Guangdong Provincial People's Hospital | 40 | 2018-03-01 | 2020-09-18 |
| Comparison of Optimal Hypertension Regimens Amlodipine, Lisinopril, Amiloride - Hypertension | Phase 4 | Completed | Cambridge University Hospitals NHS Foundation Trust | 940 | 2016-11-01 | 2025-09-05 |
| DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease Amiloride, Hydrochlorothiazide, Low-sodium diet - Chronic Kidney Disease | Phase 4 | Completed | Erasmus Medical Center | 28 | 2016-09-01 | 2018-04-20 |
| Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension Spironolactone, Furosemide,, Amiloride - Hypertension Resistant to Conventional Therapy | Phase 4 | Completed | Sao Jose do Rio Preto Medical School | 72 | 2015-09-01 | 2019-04-05 |
| A Crossover Pilot Study of the Effect of Amiloride on Proteinuria Amiloride, Triamterene - Proteinuria | Phase 4 | Unknown | Georgetown University | 30 | 2013-07-01 | 2020-02-07 |
| Amiloride for Resistant Hypertension Amiloride - Hypertension, Type 2 Diabetes Mellitus | Phase 4 | Completed | Ib Abildgaard Jacobsen | 80 | 2010-11-01 | 2014-04-24 |
| The Effect of Amiloride and Spironolactone in Patients With Hypertension Spironolactone, Amiloride, Placebo - Hypertension | Phase 4 | Completed | Erling Bjerregaard Pedersen | 23 | 2010-09-01 | 2012-03-28 |
| Study of Amiloride on Vascular Phenotypes in Young Adults With Prehypertension Amiloride - Prehypertension | Phase 4 | Unknown | Augusta University | 32 | 2010-09-01 | 2012-10-23 |
| Comparison of Single and Combination Diuretics in Low-Renin Hypertension Hydrochlorthiazide, Amiloride, Hydrochlorthiazide and Amiloride - Hypertension | Phase 4 | Unknown | University of Cambridge | 423 | 2009-11-01 | 2015-07-03 |
| Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI Guaifenesin, Placebo - Acute Upper Respiratory Track Infection | Phase 4 | Completed | Reckitt Benckiser Inc. | 1179 | 2009-10-01 | 2020-12-30 |
| Phase 4 Study - Mucinex D as Adjunct Therapy Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets) - Acute Respiratory Infection, Bronchitis | Phase 4 | Completed | Adams Respiratory Therapeutics | 600 | 2007-02-01 | 2008-02-06 |
Hypertension (5) · Renal Insufficiency, Chronic (2) · Bipolar Disorder (1) · Bronchitis (1) · Diabetes Mellitus, Type 2 (1) · Hypertension Resistant to Conventional Therapy (1) · Polycystic Kidney Diseases (1) · Polycystic Kidney, Autosomal Dominant (1) · Prehypertension (1) · Proteinuria (1) · Rhinosinusitis (1)
Erasmus Medical Center (2) · Adams Respiratory Therapeutics (1) · Assistance Publique - Hôpitaux de Paris (1) · Augusta University (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Erling Bjerregaard Pedersen (1) · Georgetown University (1) · Guangdong Provincial People's Hospital (1) · Ib Abildgaard Jacobsen (1) · Reckitt Benckiser Inc. (1) · Sao Jose do Rio Preto Medical School (1) · University of Cambridge (1) · Yonsei University (1)
United States (4) · Denmark (2) · Netherlands (2) · United Kingdom (2) · Brazil (1) · China (1) · France (1) · South Korea (1)
Ewout J Hoorn, MD, PhD (1) · Helmut Albrecht, M.D. (1) · Ian Wilkinson (1) · Ib A Jacobsen, DMSc (1) · Juan C Yugar-Toledo, MD, PhD (1) · M. Salih, MD, PhD (1) · Professor MJ Brown (1) · Solveig K Matthesen, Cand.Med (1) · Sungha Park (1) · Wen Shen, MD, PhD (1)
PMID 12479763, PMID 15106785, PMID 18391085, PMID 20651602, PMID 21423678, PMID 21444835, PMID 21502568, PMID 22948302, PMID 24410943, PMID 26253567, PMID 28761581, PMID 29433578, PMID 30092411, PMID 31791376, PMID 31996411, PMID 33957621, PMID 34164803, PMID 39356039, PMID 40366680, PMID 40859651, PMID 42247265
2009 (1)